CompoAtlas

SIROP SOMMEIL BIO

Food supplement declared in France, declaration No 2022-11-1178, decision dated 24 November 2022

SIROP SOMMEIL BIO (ORFITO) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
ORFITO
Food business operator placing the product on the market
BioUltime
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Sirop
Daily dose
2 cuillères à café (10 ml)
Directions for use
cuillères à café avant le coucher
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement antihypertenseur, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil
Flavourings
/

Declaration 189853, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Citrus aurantium L.FleurExtrait fluide aqueux125 mg
Crataegus laevigata (Poir.) DC.Sommités fleuriesExtrait fluide aqueux125 mg
Lavandula angustifolia Mill.FleurExtrait fluide aqueux125 mg
Matricaria chamomilla L.FleurExtrait fluide aqueux125 mg
Melissa officinalis L.FeuilleExtrait fluide aqueux125 mg
Origanum majorana L.FeuilleExtrait fluide aqueux125 mg

Other active ingredients

NamePer day
mielnot declared

Additives

E422, E415, E330

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : ORFITO

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line